SPDR MSCI EAFE StrategicFactors ETF QEFA puts together a portfolio of foreign developed-markets stocks that are cheap, fundamentally sound, and stable, all for a low cost. These traits give the portfolio a defensive stance, but one that should continue to outperform the MSCI ACWI ex USA Index on a risk-adjusted basis over the long term.
SPDR® MSCI EAFE StrategicFactors ETF QEFA
Morningstar’s Analysis QEFA
Will QEFA outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 17.3
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk A/S Class B | 2.44 | 23.5 Mil | Healthcare |
ASML Holding NV | 2.28 | 22.0 Mil | Technology |
Nestle SA | 2.15 | 20.8 Mil | Consumer Defensive |
AstraZeneca PLC | 1.97 | 19.1 Mil | Healthcare |
Novartis AG Registered Shares | 1.79 | 17.3 Mil | Healthcare |
Roche Holding AG | 1.71 | 16.5 Mil | Healthcare |
Unilever PLC | 1.40 | 13.5 Mil | Consumer Defensive |
Lvmh Moet Hennessy Louis Vuitton SE | 1.33 | 12.8 Mil | Consumer Cyclical |
BHP Group Ltd | 1.13 | 11.0 Mil | Basic Materials |
GSK PLC | 1.09 | 10.6 Mil | Healthcare |